▶ Brain Cancer - Clinical Trials
PHASE II TRIAL OF MOTEXAFIN GADOLINIUM WITH WHOLE BRAIN RADIATION THERAPY FOLLOWED BY STEREOTACTIC RADIOSURGERY BOOST IN THE TREATMENT OF PATIENTS WITH BRAIN METATASES
PCYC-0224
PI: Robert Timmerman, MD -- Coordinator: Candice Price, RN
▶ Breast Cancer - Clinical Trials
PHASE III TRIAL OF OBSERVATION +/- TAMOXIFEN VS. RT +/- TAMOXIFEN FOR GOOD RISK DUCT CARCINOMA IN-SITU (DCIS) OF THE FEMALE BREAST
RTOG 9804, UTSW IRB# 062004-003
PI: Dan Garwood, MD -- Coordinator: Jennifer Sheppard
A RANDOMIZED PHASE II STUDY OF CONVENTIONAL WHOLE BREAST IRRADIATION (WBI) VERSUS PARTIAL BREAST IRRADIATION (PBI) FOR WOMEN WITH STAGE 0, I or II BREAST CANCER
RTOG 0413, UTSW IRB# 052005-007
PI: Ann Spangler, MD -- Coordinator: Allison Rodarte
▶ Gastrointestinal Cancer - Clinical Trials
A PHASE I TRIAL OF STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH HEPATIC METASTASES
UTSW IRB# 062004-005
PI: Robert Timmerman, MD -- Coordinator: Jennifer Sheppard
▶ Genitourinary Cancer - Clinical Trials
PHASE I TRIAL OF STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH TUMORS OF THE KIDNEY
UTSW IRB# 122004-002
PI: L. Chinsoo Cho, MD -- Coordinator: Carolyn Zwartjes
A PHASE III RANDOMIZED STUDY OF HIGH DOSE 3D-CRT/IMRT VERSUS STANDARD DOSE 3D-CRT/IMRT IN PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER
RTOG P-0126, UTSW IRB# 082004-055
PI: David Pistenmaa, MD -- Coordinator: Jennifer Sheppard
▶ Gynecological (TBA)
▶ Head & Neck Cancer - Clinical Trials
A PHASE II RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTRE COMPARATIVE STUDY OF ZD1839 250 MG OR 500 MG (IRESSATM ) GIVEN EITHER CONTINUOUSLY OR CONCOMITANTLY WITH CISPLATIN PLUS RADIOTHERAPY FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED UNRESECTED LATE STAGE III/IV NON-METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
UTSW IRB# 082004-015
PI: Phuc Nguyen, MD -- Coordinator: Allison Rodarte
A PHASE II RANDOMIZED TRIAL OF SURGERY FOLLOWED BY CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
RTOG 0234, UTSW IRB# 092004-029
PI: Phuc Nguyen, MD -- Coordinator: Carolyn Zwartjes
Pending: A PILOT PHASE II STUDY WITH CETUXIMAB AND RADIATION THERAPY FOR PATIENTS WITH LOCALLY ADVANCED EPIDERMAL GROWTH FACTOR RECEPTOR POSITIVE AND UNDETECTABLE ESOPHAGEAL AND GE JUNCTION CARCINOMAS
UTSW IRB# 042005-032
PI: Carlos Becerra, MD -- Coordinator: Allison Rodarte
▶ Lymphoma/Sarcoma/Melanoma (TBA)
▶ Pediatrics (TBA)
▶ Thoracic/ Lung Cancer - Clinical Trials
A PHASE II STUDY OF DOSE-DENSE DOCETAXEL AND CISPLATIN EVERY 2 WEEKS WITH PEGFILGRASTIM AND DARBEPOETIN ALPHA WITH AND WITHOUT THE CHEMOPROTECTOR BNP 7787 IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
CALGB 30303, UTSW IRB# 072005-006
PI: Jonathan Dowell, MD -- Coordinator: Candice Price, RN
RADIATION THERAPY FOLLOWED BY CONSOLIDATION ALIMTA/GEMCITABINE FOR PATIENTS WITH FAVORABLE PROGNOSIS INOPERABLE STAGE IIIA/B NON-SMALL CELL LUNG CANCER (NSCLC)
UTSW IRB# 082005-020
PI: Hak Choy, MD -- Coordinator: Allison Rodarte
A PHASE III COMPARISON OF PROPHYLACTIC CRANIAL IRRADIATION VERSUS OBSERVATION IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
RTOG L-0214, UTSW IRB# 052004-007
PI: Robert Timmerman, MD -- Coordinator: Allison Rodarte
A PHASE II STUDY OF CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY DOCETAXEL, CARBOPLATIN AND RADIATION THERAPY FOLLOWED BY CONSOLIDATION CHEMOTHERAPY WITH DOCETAXEL AND CARBOPLATIN FOR LOCALLY ADVANCED INOPERABLE NON-SMALL CELL LUNG CANCER
VICC THO 0319, UTSW IRB# 042004-013
PI: Hak Choy, MD -- Coordinator: Jennifer Sheppard
A PHASE II/III RANDOMIZED TRIAL OF TWO DOSES (PHASE III-STANDARD VS. HIGH) AND TWO HIGH DOSE SCHEDULES (PHASE II-ONCE VS. TWICE DAILY) FOR DELIVERING PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH LIMITED DISEASE SMALL CELL LUNG CANCER
RTOG 0212, UTSW IRB# 052004-017
PI: Robert Timmerman, MD -- Coordinator: Carolyn Zwartjes
A PHASE II TRIAL OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN THE TREATMENT OF PATIENTS WITH MEDICALLY INOPERABLE STATE I/II NON-SMALL CELL LUNG CANCER
RTOG 0236, UTSW IRB# 092004-023
PI: Robert Timmerman, MD -- Coordinator: Jennifer Sheppard
A PHASE I/II STUDY WITH SATRAPLATIN AND SIMULTANEOUS RADIATION IN NON-SMALL CELL LUNG CANCER
JM 216, UTSW IRB# 082004-013
PI: Hak Choy, MD -- Coordinator: Jennifer Sheppard
Pending Closure: PHASE I STUDY OF IRINOTECAN AND CISPLATIN IN COMBINATION WITH TWICE DAILY THORACIC RADIOTHERAPY (45 Gy) OR ONCE DAILY THORACIC RADIOTHERAPY (70 Gy) FOR PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER
RTOG 0241, UTSW IRB# 082004-059
PI: Robert Timmerman, MD
Pending: A RANDOMIZED PHASE III TRIAL OF SURGERY ALONE OR SURGERY PLUS PREOPERATIVE PACLITAXEL/CARBOPLATIN IN CLINICAL STAGE IB (T2N0), II (TI-2N1, T3N0) AND SELECTED IIIA (T3N1) NON-SMALL CELL LUNG CANCER
RTOG 0015, UTSW IRB# - Pending
